Raymond James & Associates’s Novan, Inc. Common Stock NOVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,123
Closed -$64K 4252
2021
Q1
$64K Buy
4,123
+53
+1% +$797 ﹤0.01% 3831
2020
Q4
$33K Buy
4,070
+672
+20% +$3.67K ﹤0.01% 3657
2020
Q3
$16K Buy
3,398
+1,000
+42% +$5.67K ﹤0.01% 3520
2020
Q2
$12K Sell
2,398
-56
-2% -$237 ﹤0.01% 3474
2020
Q1
$12K Sell
2,454
-150
-6% -$852 ﹤0.01% 3429
2019
Q4
$82K Sell
2,604
-50
-2% -$1.17K ﹤0.01% 3499
2019
Q3
$68K Buy
2,654
+50
+2% +$1.3K ﹤0.01% 3441
2019
Q2
$70K Hold
2,604
﹤0.01% 3459
2019
Q1
$25K Buy
2,604
+454
+21% +$5.74K ﹤0.01% 3522
2018
Q4
$18K Buy
+2,150
New +$43.9K ﹤0.01% 3442
2018
Q2
Sell
-2,000
Closed -$59K 3691
2018
Q1
$59K Buy
+2,000
New +$67K ﹤0.01% 3308

Other funds holding NOVN

Raymond James & Associates's NOVN Position: Q2 2021 in Review

Raymond James & Associates sold out of Novan, Inc. Common Stock (NOVN) in Q2 2021, closing a stake of 4,123 shares — an estimated $64K sold.

Raymond James & Associates first reported a position in NOVN in Q1 2018 and held it in 11 quarters. The position peaked at $82K in Q4 2019. 33 funds tracked by Wall St. Rank hold NOVN as of Q2 2021.

  • Raymond James & Associates reported no remaining Novan, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Raymond James & Associates sold 4,123 Novan, Inc. Common Stock shares in Q2 2021, an estimated $64K.
  • Raymond James & Associates first reported a position in Novan, Inc. Common Stock in Q1 2018 and held it in 11 quarters.
  • Raymond James & Associates's Novan, Inc. Common Stock position peaked at $82K in Q4 2019.
  • 33 funds tracked by Wall St. Rank held Novan, Inc. Common Stock as of Q2 2021.

Based on Raymond James & Associates's 13F filing for Q2 2021, filed 11 Aug 2021.